165 related articles for article (PubMed ID: 3114582)
1. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
[TBL] [Abstract][Full Text] [Related]
2. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
Shriver DA; Katz LB; Rosenthale ME
Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
[TBL] [Abstract][Full Text] [Related]
3. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
5. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
[TBL] [Abstract][Full Text] [Related]
6. Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effects.
Katz LB; Shriver DA
Toxicol Appl Pharmacol; 1989 Oct; 101(1):36-46. PubMed ID: 2508266
[TBL] [Abstract][Full Text] [Related]
7. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
Morris GP; Keenan CM; Shriver DA
Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
[TBL] [Abstract][Full Text] [Related]
8. Rioprostil prevents aspirin-induced fecal blood loss in dogs. Correlation of Hemoquant (Hb) with endoscopic findings.
Katz LB; Fernandez JA; Schwartz S; Shriver DA
Digestion; 1989; 42(4):217-23. PubMed ID: 2509266
[TBL] [Abstract][Full Text] [Related]
9. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
Katz LB; Genna T; Greeley GH; Shriver DA
Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
[TBL] [Abstract][Full Text] [Related]
10. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
11. Rioprostil prevents gastric bleeding induced by nonsteroidal antiinflammatory drugs in dogs and arthritic rats.
Katz LB; Capetola RJ; Argentieri DC; Moore LE; Genna T; Porter MC; Jasty V; Hartnagel RE; Abrutyn D; Shriver DA
J Rheumatol; 1986 Oct; 13(5):887-94. PubMed ID: 3102726
[TBL] [Abstract][Full Text] [Related]
12. Antiulcer effect of rioprostil, a prostaglandin E1 analog, in combination with antacid.
Katz LB; Genna T; Shriver DA
Life Sci; 1986 Sep; 39(11):1013-9. PubMed ID: 3091974
[TBL] [Abstract][Full Text] [Related]
13. Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil.
Katz LB; Genna T; Fuller BL; Tolman EL; Shriver DA
Agents Actions; 1987 Oct; 22(1-2):134-43. PubMed ID: 3120518
[TBL] [Abstract][Full Text] [Related]
14. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
15. The effects of rioprostil on gastric emptying and intragastric acidity.
Penston JG; Johnston DA; Wormsley KG
Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
[TBL] [Abstract][Full Text] [Related]
16. Rioprostil and the gastric mucus-bicarbonate barrier.
Guslandi M; Fasani R; Tittobello A
Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
[TBL] [Abstract][Full Text] [Related]
17. Influence of chronic rioprostil treatment on gastric endocrine function.
Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
[TBL] [Abstract][Full Text] [Related]
18. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
[TBL] [Abstract][Full Text] [Related]
19. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
20. Effect of rioprostil on the gastric acid and bicarbonate secretion in patients with gastric ulcer.
Krastev Z; Deredjian S; Matincheva R; Spasova Z; Karakasheva V
Scand J Gastroenterol Suppl; 1989; 164():141-5. PubMed ID: 2510258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
